Global Health Governance Programme
We research how global institutions, finance and rules can better serve the needs of people across the world. We focus on three main areas: Improving the effectiveness of international health organizations, tracking financing to global public health and developing better tools for priority-setting
We are based in the Centre for Global Health Research within the Usher Institute for Population Health Sciences and Informatics in the University of Edinburgh Medical School.
LATEST BLOG POSTS
“Between a high, solid wall and an egg that breaks against it, I will always stand on the side of the egg… Each of us is, more or less, an egg. Each of us is a unique, irreplaceable soul enclosed in a fragile shell. This is true of me, and it is true of each of you. And each of us, to a greater or lesser degree, is confronting a high, solid wall. The wall has a name: It is The System. The System is supposed to protect us, but sometimes it takes on a life of its own…”
Haruki Murakami, 2009
How do we measure the impact of health interventions and how does the measurement of health or of health’s absence impact global health discourse and funding? How is the measuring of health co-constructive of ideas about what health is and what kinds of negotiations are underway in health development in Senegal as the country works towards universal health coverage?
In this blog post I will offer reflections on the World Bank’s involvement in the broad field of human rights.
Health policy-related decisions are often made based on global burden of disease estimates, as well as economic framings of disease control and prevention. But how do other social sciences fit into this agenda – and how do they challenge it?
Investors seem to love the World Bank's new pandemic insurance. Should donors love it too?
Between September 25-27, IHME hosted a celebration of the 20th anniversary of the four-part publication of the global burden of disease study in The Lancet by drawing together policy makers from various global health organizations and GBD collaborators from around the world.
In this blog post, I briefly introduce the rise of health economics in the 20th century and a few methods for economically measuring health investment as a means to provide some context to current health care financing debates.
When did PPPs become a model for global health investment, and how popular are they today?
Georgetown University and the Global Health Governance Programme at the University of Edinburgh will be hosting a 2 day event on the 23rd and 24th May 2018.
This is an invite only workshop and speakers include Professor Lawrence Gostin, Professor Rebecca Katz, Dr Emily Mendenhall, Professor Devi Sridhar, Dr Anuj Kapilashrami and Mark Hellowell.
The Global Health Governance Programme along with Edinburgh Infectious Diseases and the Centre for Medical Anthropology are delighted to announce that we are co-hosting a talk by Dr Emily Mendenhall on the 24th May at 2pm. The talk is entitled “Syndemic Diabetes: Entanglements of Poverty, Trauma, and AIDS.”
For further information and to book your place, please see link:- https://www.eventbrite.co.uk/e/syndemic-diabetes-entanglements-of-poverty-trauma-and-aids-tickets-41818946595
Governing Global Health: Who Runs the World and Why
Chelsea Clinton and Devi Sridhar
Saturday 2 June 2018, 5.30pm Venue: Oxfam Moot
Governments, NGOs and corporations collaborate across the world on campaigns to respond to global health issues such as AIDS, Ebola, SARS and malaria. But how do you regulate these PPPs (private-public partnerships)? And how do you analyse the accountability, effectiveness and sustainability of the biggest campaigns? Clinton is Vice Chair of the Clinton Foundation and a Lecturer at the Mailman School of Public Health at Columbia. Sridhar is Professor of Global Public Health at the University of Edinburgh. Chaired by the science writer and climatologist Gabrielle Walker.